Acumen Pharmaceuticals (NasdaqGS:ABOS) Earnings Call Presentation

Results Presentation 3Q2 5 The ecosystem of solutions created to simplify Brazil's healthcare market Opening Remarks CEO: Leonardo Byrro Priorities Established for 2025 Working Capital Quality x Quantity Operational Excellence Operational Excellence: Expected Improvements 4 ▪ Adjustment of operations with a focus on efficiency and cash generation, reducing the pace of growth. ▪ Discontinuation of businesses with below-expected returns (ROIC) and margin expansion across all business lines. ▪ Reduction of exp ...